Aurora Cannabis vs IM Cannabis
ACB and IMCC side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACB and IMCC compare
Aurora Cannabis grew revenue faster over the last twelve months (11.0% versus 1.3% for IM Cannabis).
Aurora Cannabis scores higher on the StockData Score (6 against 4 for IM Cannabis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACB | IMCC |
|---|---|---|
| Size and price | ||
| Share price | $5.05 | $0.575 |
| Change, 1 year | 8.1% | −98.7% |
| Change, 5 years | −92.8% | −100.0% |
| Beta (5Y) | 1.32 | 1.36 |
| Employees | – | 95 |
| StockData Score | ||
| Total score | 6 (better) | 4 |
| Valuation score | 0 | 0 |
| Growth score | 1 | 1 |
| Performance score | 0 | 2 (better) |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 11.0% (better) | 1.3% |
| Revenue growth, 5Y average | 5.5% | 28.1% (better) |
| EPS growth (TTM) | −5450% | – |
| Profitability | ||
| Gross margin | 42.6% (better) | 17.7% |
| Operating margin | – | −21.2% |
| Net margin | – | −20.7% |
| FCF margin | – | 8.6% |
| Return on invested capital | – | −82.3% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −3.3× |
| Current ratio | 5.94 (better) | 0.56 |
| Piotroski F-score | – | 4 |
| Ownership | ||
| Held by institutions | 8.9% | – |
| Held by insiders | 0.00% | 0.00% |
Go deeper
- ACB stock overview
- ACB income statement
- ACB valuation and score
- IMCC stock overview
- IMCC income statement
- IMCC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.